Silicone Oil Emulsification after Vitrectomy for Rhegmatogenous Retinal Detachment

Table 3

Comparison of clinical factors and characteristics of emulsified silicone oil droplets between patients using or not using antiglaucoma medications at the time of silicone oil removal.

Variable	Use of antiglaucoma medications
	Yes	No
Patients	17	21
Age (years)	55 ± 13	56 ± 9	1.000
AL (mm)	25.32 ± 2.16	26.57 ± 2.80	0.189
IOP (mmHg)	21.4 ± 59	15.6 ± 2.8
Duration of SO in situ (days)	179 ± 52	201 ± 122	0.794
Time course of vitrectomy (min)	70 ± 17	70 ± 15	0.862
Total number of droplets	0.96 × 10^6 ± 0.77 × 10^6	2.78 × 10^6 ± 5.18 × 10^6	0.586
Droplets in different diameter
1-<2 μm	0.73 × 10^6 ± 0.67 × 10^6	2.59 × 10^6 ± 5.13 × 10^6	0.243
2-<3 μm	1.00 × 10^5 ± 0.71 × 10^5	1.00 × 10^5 ± 0.60 × 10^5	0.772
3-<4 μm	6.37 × 10^4 ± 11.90 × 10^4	3.45 × 10^4 ± 2.95 × 10^4	0.794
4-<5 μm	4.30 × 10^4 ± 11.15 × 10^4	3.00 × 10^4 ± 4.23 × 10^4	0.523
5–<7 μm	1.76 × 10^4 ± 1.81 × 10^4	0.84 × 10^4 ± 1.43 × 10^4
7–<12 μm	0.71 × 10^4 ± 0.58 × 10^4	0.35 × 10^4 ± 0.58 × 10^4

Values are expressed as the mean ± standard deviation. was considered statistically significant. AL, axial length; IOP, intraocular pressure; SO, silicone oil; PPV, pars plana vitrectomy.